Switch to: References

Add citations

You must login to add citations.
  1. Closed-Loop Neuromodulation and Self-Perception in Clinical Treatment of Refractory Epilepsy.Tobias Haeusermann, Cailin R. Lechner, Kristina Celeste Fong, Alissa Bernstein Sideman, Agnieszka Jaworska, Winston Chiong & Daniel Dohan - 2023 - American Journal of Bioethics Neuroscience 14 (1):32-44.
    Background: Newer “closed-loop” neurostimulation devices in development could, in theory, induce changes to patients’ personalities and self-perceptions. Empirically, however, only limited data of patient and family experiences exist. Responsive neurostimulation (RNS) as a treatment for refractory epilepsy is the first approved and commercially available closed-loop brain stimulation system in clinical practice, presenting an opportunity to observe how conceptual neuroethical concerns manifest in clinical treatment. Methods: We conducted ethnographic research at a single academic medical center with an active RNS treatment program (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   8 citations  
  • Changes in Personality Associated with Deep Brain Stimulation: a Qualitative Evaluation of Clinician Perspectives.Cassandra J. Thomson, Rebecca A. Segrave & Adrian Carter - 2019 - Neuroethics 14 (1):109-124.
    Gilbert et al. argue that the neuroethics literature discussing the putative effects of Deep Brain Stimulation on personality largely ignores the scientific evidence and presents distorted claims that personality change is induced by the DBS stimulation. This study contributes to the first-hand primary research on the topic exploring DBS clinicians’ views on post-DBS personality change among their patients and its underlying cause. Semi-structured interviews were conducted with sixteen clinicians from various disciplines working in Australian DBS practice for movement disorders and/or (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   14 citations  
  • Ethics and ego dissolution: the case of psilocybin.William R. Smith & Dominic Sisti - 2021 - Journal of Medical Ethics 47 (12):807-814.
    Despite the fact that psychedelics were proscribed from medical research half a century ago, recent, early-phase trials on psychedelics have suggested that they bring novel benefits to patients in the treatment of several mental and substance use disorders. When beneficial, the psychedelic experience is characterized by features unlike those of other psychiatric and medical treatments. These include senses of losing self-importance, ineffable knowledge, feelings of unity and connection with others and encountering ‘deep’ reality or God. In addition to symptom relief, (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   16 citations  
  • Mapping the Ethical Issues of Brain Organoid Research and Application.Tsutomu Sawai, Yoshiyuki Hayashi, Takuya Niikawa, Joshua Shepherd, Elizabeth Thomas, Tsung-Ling Lee, Alexandre Erler, Momoko Watanabe & Hideya Sakaguchi - 2022 - American Journal of Bioethics Neuroscience 13 (2):81-94.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   31 citations  
  • Losing Meaning: Philosophical Reflections on Neural Interventions and their Influence on Narrative Identity.Muriel Https://Orcidorg Leuenberger - 2021 - Neuroethics (3):491-505.
    The profound changes in personality, mood, and other features of the self that neural interventions can induce can be disconcerting to patients, their families, and caregivers. In the neuroethical debate, these concerns are often addressed in the context of possible threats to the narrative self. In this paper, I argue that it is necessary to consider a dimension of impacts on the narrative self which has so far been neglected: neural interventions can lead to a loss of meaning of actions, (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   6 citations  
  • In Defense of Narrative Authenticity.Muriel Https://Orcidorg Leuenberger - 2020 - Cambridge Quarterly of Healthcare Ethics 29 (4):656-667.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   10 citations  
  • Incoming ethical issues for deep brain stimulation: when long-term treatment leads to a ‘new form of the disease’.Frederic Gilbert & Mathilde Lancelot - 2021 - Journal of Medical Ethics 47 (1):20-25.
    Deep brain stimulation has been regarded as an efficient and safe treatment for Parkinson’s disease since being approved by the Food and Drug Administration in 1997. It is estimated that more than 150 000 patients have been implanted, with a forecasted rapid increase in uptake with population ageing. Recent longitudinal follow-up studies have reported a significant increase in postoperative survival rates of patients with PD implanted with DBS as compared with those not implanted with DBS. Although DBS tends to increase (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   7 citations  
  • Ethical Implications of Closed Loop Brain Device: 10-Year Review.Swati Aggarwal & Nupur Chugh - 2020 - Minds and Machines 30 (1):145-170.
    Closed Loop medical devices such as Closed Loop Deep Brain Stimulation and Brain Computer Interface are some of the emerging neurotechnologies. New generations of implantable brain–computer interfaces have recently gained success in human clinical trials. These implants detect specific neuronal patterns and provide the subject with information to respond to these patterns. Further, Closed Loop brain devices give control to the subject so that he can respond and decide on a therapeutic goal. Although the implants have improved subjects’ quality of (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   5 citations